Clinical Trial Patient Recruitment: Market Size & Forecast 2026

The global clinical-trial patient recruitment market sits at approximately USD 11.2 billion in 2025 (base year), held in a structurally expanding balance: study-start volumes are recovering from the 2023 sponsor-pullback, demand for decentralised and AI-enabled pre-screening is outrunning the supply of validated patient databases, and a fragmented but rapidly consolidating specialist-supplier base is taking share from the legacy CRO bundled offering. The category carries a 6.4% CAGR through 2032 in our base case, with end-use mix anchored to oncology and cardiometabolic trials. > **Analyst Take.** the consensus is too cautious on category size and too aggressive on supplier share concentration. Our base case puts 2025 spend at roughly USD 11.2B, not the USD 1.4-1.6B number that several published service-segment estimates cite, because the narrow service-only definition excludes the patie

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.